THE CHALLENGE

We need better ways to communicate the science and the challenges of addressing neurodegenerative diseases.

The new science of Alzheimer’s is emerging in exciting areas including biomarker utilities, genetics, and inflammatory targets, but current visuals and storytelling tools for scientists are not adequate; they don’t communicate the exciting potential of these new research paradigms as well as they could.